NCT05686239 A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS) Status COMPLETED Phase PHASE2
NCT05670197 Service User and Staff Views on Digital Remote Monitoring for Psychosis Status COMPLETED Phase N/A
NCT05667961 Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation Status COMPLETED Phase N/A
NCT05663749 Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics Status COMPLETED Phase PHASE4
NCT05662137 The Effect of Recognition and Expression of Emotions Program Applied to Schizophrenia Patients Status COMPLETED Phase NA
NCT05660070 Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness Status COMPLETED Phase NA
NCT05658510 Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) Status COMPLETED Phase PHASE3
NCT05654870 Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for Schizophrenia Status TERMINATED Phase PHASE3
NCT05648591 Safety and Tolerability of Open-Labeled Iloperidone in Adolescents Status RECRUITING Phase PHASE4
NCT05646264 A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia Status UNKNOWN Phase PHASE4
NCT05643196 Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia Status COMPLETED Phase PHASE2
NCT05643170 An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of Schizophrenia Status TERMINATED Phase PHASE3
NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives Status RECRUITING Phase N/A
NCT05628103 A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication Status COMPLETED Phase PHASE3
NCT05623228 The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Training. Status COMPLETED Phase PHASE2
NCT05599373 Optimal rTMS for Cognitive Deficits and Negative Symptoms in Schizophrenia Status UNKNOWN Phase NA